NCT06737835View on ClinicalTrials.gov

Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma

Not yet recruitingOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 1, 2027

Conditions
Lymphoma
Interventions
DEVICE

18 FDG

18 flurodeoxy glucose PET/CT

Trial Locations (1)

Unknown

Nuclear medicine- Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06737835 - Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma | Biotech Hunter | Biotech Hunter